Dehydrocholesterol Reductase (DHCR)

Dehydrocholesterol Reductase

Dehydrocholesterol reductases (DHCRs) are critical sterol reductases in the terminal steps of cholesterol biosynthesis; the isoforms DHCR7 and DHCR24 catalyze distinct double-bond reduction reactions and are associated with different hereditary disorders of sterol metabolism. DHCR24 and DHCR7 interact both physically and functionally; knockdown of DHCR24 in cells abolishes DHCR7 activity, whereas overexpression of functional DHCR24 enhances DHCR7 activity, suggesting cooperative regulation at the terminal stage of cholesterol synthesis. Specifically, DHCR24 (24-dehydrocholesterol reductase) reduces the C24 double bond of sterol intermediates, converting desmosterol into cholesterol; functional deficiency of DHCR24 leads to desmosterol accumulation and causes the autosomal recessive disorder desmosterolosis. DHCR24 inhibitors, such as amiodarone, can directly inhibit the enzyme and promote desmosterol accumulation. DHCR7 (7-dehydrocholesterol reductase) reduces the Δ7 double bond of 7-dehydrocholesterol (7DHC) to produce cholesterol and serves as the terminal enzyme of the Kandutsch–Russell pathway; functional deficiency of DHCR7 results in 7DHC accumulation and insufficient cholesterol production, constituting the direct genetic and biochemical basis of Smith–Lemli–Opitz syndrome (SLOS).